Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
A total of 300 women with lactational infectious mastitis will daily ingest 9 log10 cfu of
Lactobacillus salivarius HN6, Lactobacillus reuteri CR20 or Lactobacillus fermentum LC40 for
4 weeks. The three lactobacilli strains were originally isolated from milk of healthy women.
On days 0 and 28, milk samples will be collected, and staphylococci/streptococci and
lactobacilli will be counted and identified. Evolution of clinical signs will be recorded by
midwifes on days 0, 7, 14 and 28.